SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055581
Filing Date
2024-05-08
Accepted
2024-05-08 16:00:34
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q enta-20240331.htm   iXBRL 10-Q 1601137
2 EX-10.2 enta-ex10_2.htm EX-10.2 32336
3 EX-31.1 enta-ex31_1.htm EX-31.1 10894
4 EX-31.2 enta-ex31_2.htm EX-31.2 10904
5 EX-32.1 enta-ex32_1.htm EX-32.1 10354
6 GRAPHIC img216959928_0.jpg GRAPHIC 645173
  Complete submission text file 0000950170-24-055581.txt   8114094

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT enta-20240331.xsd EX-101.SCH 947061
67 EXTRACTED XBRL INSTANCE DOCUMENT enta-20240331_htm.xml XML 1213062
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 24925697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)